Tag: big pharma

Scheduling of Kratom by DEA Protects Big Pharma

The DEA has announced the scheduling of Kratom, a southeast Asian plant used extensively in traditional medicine, to Schedule 1 beginning 30 September. According to the DEA website, “Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.”

Kratom, a plant native to Southeast Asian countries like Thailand, has long been used in traditional medicine. Advocates claim the substance has great potential to mitigate the effects of opioid addiction and in the treatment of chronic pain, which is typically treated now with opioid drugs like Oxycodone.

Who Runs Washington? The Long Reach of Big-Pharma

Like a mythical sea monster, the true nature of a Wall Street-London centered global corporatocracy is often talked about but rarely seen. However, on rare occasions, a tentacle breaks the surface and affords the public an opportunity to examine and assess its true, gargantuan dimensions.

Just such a moment occurred when leaked diplomatic letters from the Colombian Embassy in Washington D.C. revealed just how far the United States government is willing to go on behalf of the corporate-financier interests that clearly shape the entirety of its foreign policy.

The Intercept would report in its article, “Leaks Show Senate Aide Threatened Colombia Over Cheap Cancer Drug,” that:

Leaked diplomatic letters sent from Colombia’s Embassy in Washington describe how a staffer with the Senate Finance Committee, which is led by Sen. Orrin Hatch, R-Utah, warned of repercussions if Colombia moves forward on approving the cheaper, generic form of a cancer drug.